同: lopinavir/ritonavir

WordNet

sound loudly and sonorously; "the bells rang" (同)peal
a toroidal shape; "a ring of ships in the harbor"; "a halo of smoke" (同)halo, annulus, doughnut, anchor ring
jewelry consisting of a circlet of precious metal (often set with jewels) worn on the finger; "she had rings on every finger"; "he noted that she wore a wedding band" (同)band
a characteristic sound; "it has the ring of sincerity"
a platform usually marked off by ropes in which contestants box or wrestle
the sound of a bell ringing; "the distinctive ring of the church bell"; "the ringing of the telephone"; "the tintinnabulation that so voluminously swells from the ringing and the dinging of the bells"--E. A. Poe (同)ringing, tintinnabulation
attach a ring to the foot of, in order to identify; "ring birds"; "band the geese to observe their migratory patterns" (同)band
make (bells) ring, often for the purposes of musical edification; "Ring the bells"; "My uncle rings every Sunday at the local church" (同)knell
of a color at the end of the color spectrum (next to orange); resembling the color of blood or cherries or tomatoes or rubies (同)reddish, ruddy, blood-red, carmine, cerise, cherry, cherry-red, crimson, ruby, ruby-red, scarlet
red color or pigment; the chromatic color resembling the hue of blood (同)redness
the 18th letter of the Roman alphabet (同)r
a long-playing phonograph record; designed to be played at 33.3 rpm (同)L-P
the 12th letter of the Roman alphabet (同)l

PrepTutorEJDIC

『指輪』 / 『輪』,環;輪形,円形 / (円形の)サーカス演技場,公演場,競技場;(ボクシング・レスリングの)リング / 《複数形で》(体操の)つり輪 / (不法な目的で結託した)(…の)徒党,一味《+『of』+『名』》 / (原子の)環 / …を円形に取り囲む,円で囲む《+『about』(『around』,《英》『round』)+『名,』+『名』+『about』(『around』,《英》『round』)+『名』》 / 〈動物〉‘に'鼻輪(首輪,足輪)をはめる / (遊びで)…‘に'輪を投げる / 環状に動く,輪を描く
〈鐘・ベルなどが〉『鳴る』 / 《『ring』+『形』〈補〉》(…のように)聞こえる / (…を)ベルを鳴らして求める《+『for』+『名』》 / 〈音声・楽器などが〉鳴り響く;〈場所が〉(音などで)満ちる《+『with』+『名』》 / 耳鳴りがする / 〈鐘・ベルなど〉‘を'『鳴らす』 / 〈人〉‘を'(鐘などを)『鳴らして呼ぶ』;…‘を'鐘を鳴らして知らせる / 《英》…‘に'電話をかける《+『up』+『名』,+『名』+『up』》 / 《単数形で》(鐘・ベルなどの)『鳴る音,響き』《+『of』+『名』》 / 鐘(ベルなど)を鳴らすこと;ベル(など)が鳴ること / 《単数形で》(…の)固有の響き,調子,感じ《+『of』+『名』》 / 《話》電話をかけること
〈U〉〈C〉『赤,』『赤色;』赤い絵の具(染料) / 〈U〉赤い服 / 〈C〉《しばしば『R-』》《話》《時に軽べつして》アカ,共産主義者;過激論(主義)者 / 〈U〉《通例the ~》(会計の)赤字,負債 / 『赤い』,赤色の / (顔・目などが)赤くなった;血に染った / 赤い服を着た;赤毛の / 《しばしば『R-』》《話》《軽べつして》共産主義の;過激な
resistance / 17歳以下父兄同伴映画の表示 / rook
エルピーレコード(1分間331/3回転のレコード;商標名)
lira(イタリアの貨幣単位リラ)

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. HIVプロテアーゼ阻害剤 hiv protease inhibitors
2. HIV感染患者における心血管疾患の疫学および危険因子 epidemiology of cardiovascular disease and risk factors in hiv infected patients
3. HIV抗レトロウイルス療法に関する臨床試験：プロテアーゼ阻害剤 clinical trials of hiv antiretroviral therapy protease inhibitors
4. HIV抗レトロウイルス療法に関する臨床試験：プロテアーゼ阻害剤と非ヌクレオシド系逆転写酵素阻害剤の比較 clinical trials of hiv antiretroviral therapy protease inhibitors versus non nucleoside reverse transcriptase inhibitors
5. HIV-2感染の治療 treatment of hiv 2 infection

English Journal

Apoptosis Pathways in HIV-1-Infected Patients Before and After Highly Active Antiretroviral Therapy: Relevance to Immune Recovery.

Pitrak DL1, Novak RM, Estes R, Tschampa J, Abaya CD, Martinson J, Bradley K, Tenorio AR, Landay AL.
AIDS research and human retroviruses.AIDS Res Hum Retroviruses.2014 Nov 11. [Epub ahead of print]
Abstract Investigations into apoptotic pathways, intrinsic and extrinsic, and the effects of highly active antiretroviral therapy (HAART) on T cell death via those pathways may provide insight into the mechanisms of and barriers to immune recovery. HIV-1-infected patients were enrolled into a random
PMID 25386736

Differential subcutaneous adipose tissue gene expression patterns in a randomized clinical trial of efavirenz or lopinavir-ritonavir in antiretroviral-naive patients.

Egaña-Gorroño L1, Martínez E2, Domingo P3, Loncà M2, Escribà T1, Fontdevila J4, Vidal F5, Negredo E6, Gatell JM7, Arnedo M8.
Antimicrobial agents and chemotherapy.Antimicrob Agents Chemother.2014 Nov;58(11):6717-23. doi: 10.1128/AAC.03481-14. Epub 2014 Aug 25.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.
PMID 25155608

Impact of Lopinavir-Ritonavir or Nevirapine on Bedaquiline Exposures and Potential Implications for Patients with Tuberculosis-HIV Coinfection.

Svensson EM1, Dooley KE2, Karlsson MO3.
Antimicrobial agents and chemotherapy.Antimicrob Agents Chemother.2014 Nov;58(11):6406-12. doi: 10.1128/AAC.03246-14. Epub 2014 Aug 11.
Concomitant treatment of tuberculosis (TB) and HIV is recommended and improves outcomes. Bedaquiline is a novel drug for the treatment of multidrug-resistant (MDR) TB; combined use with antiretroviral drugs, nevirapine, or ritonavir-boosted lopinavir (LPV/r) is anticipated, but no clinical data from
PMID 25114140

Japanese Journal

Evidence for Time-Dependent Interactions between Ritonavir and Lopinavir/Ritonavir Plasma Levels Following P-Glycoprotein Inhibition in Sprague-Dawley Rats

Plooy Michael du,Viljoen Michelle,Rheeders Malie
Biological and Pharmaceutical Bulletin 34(1), 66-70, 2011
… The interaction between verapamil, a P-glycoprotein (P-gp) inhibitor, with ritonavir and lopinavir/ritonavir (LPV/r) after acute and chronic treatment was investigated in rats. … Group 1: ritonavir, 20 mg/kg/d (n=18), group 2: ritonavir, 20 mg/kg/d plus verapamil 5 mg/kg/d (n=18), group 3: LPV/r, 80 and 20 mg/kg/d (n=17) and group 4: LPV/r, 80 and 20 mg/kg/d plus verapamil 5 mg/kg/d (n=18). …
NAID 130000402264

ロピナビル・リトナビル配合剤(LPV/r)の1日2回から1日1回投与へのスイッチ臨床試験結果

吉野宗宏,矢倉裕輝,[クワ]原健 [他],坂東裕基,小川吉彦,矢嶋敬史郎,谷口智宏,大谷成人,富成伸次郎,渡邊大,西田恭治,上平朝子,白阪琢磨
日本エイズ学会誌 = The journal of AIDS research 11(3), 250-254, 2009-08-20
NAID 10026901779

HIVプロテアーゼ阻害薬ダルナビルエタノール付加物(プリジスタ^【○!R】錠300mg)の薬理学的特徴および臨床試験成績

岩田理子,吉田慎哉,原田寧
日本薬理学雑誌 132(6), 363-369, 2008-12-01
… ビル／リトナビル（LPV/r）群に比しDRV／リトナビル（r）群の優越性が示され，DRVはウイルス学的治療失敗（Virological failure）が少なく薬剤耐性が発現しにくい新しいPIであることが示されつつある．DRV/r 600/100 mgの1日2回投与は，POWER試験から多剤耐性HIVに有効であり，且つTITAN試験から薬剤耐性がLPV/rに比し発現しにくい …
NAID 10024384429

Related Pictures

de LPV/r pour la proportion avec CV Clique na imagem para ampliar. efv vs lpv r 2 intr vs efv lpv r n riddler Subject 903 (LPV/r Monotherapy Arm) to 46 on ATV/r and from 49 to 46 on LPV/r Kaletra (Lopinavir/R, LPV/R) The proportion of subjects with viral load after switching to LPV/r Tablets dosed QD